
Cellino and Matricelf Partner for Global Expansion of Personalized Spinal Cord Injury Treatments
Cellino and Matricelf Partner for Global Expansion of Personalized Spinal Cord Injury Treatments Cellino and Matricelf (TASE: MTLF) have announced a new collaboration aimed at accelerating the global biomanufacturing of personalized spinal cord injury treatments. This partnership leverages Cellino’s cutting-edge…












